期刊文献+

尼可地尔对大鼠低氧性肺高压的影响 被引量:4

Effects of nicorandil on hypoxic pulmonary hypertension in rats
下载PDF
导出
摘要 目的:探讨线粒体ATP敏感性钾通道开放剂(mitoKATPCO)尼可地尔(nicorandil)对大鼠低氧性肺动脉高压的影响。方法:将40只大鼠随机分成对照组(C组)、低氧组(H组)、低氧+尼可地尔组(N组)与低氧+尼可地尔+5-羟基葵酸盐组(HD组),后3组置于常压低氧仓内,每周6 d,每天8 h,持续4周后测定各组大鼠平均肺动脉压(mPAP),右心肥厚指数RV/(V+S),HE染色观察肺小动脉血管壁的病理变化并检测增殖相关抗原(PCNA)。结果:慢性缺氧可诱导大鼠mPAP及RV/(LV+S)升高,大鼠肺小血管增厚重构,PCNA表达增加,尼可地尔可显著抑制上述变化,且该效应可被线粒体KATP(mitoKATP)通道特异性阻断剂5-羟基葵酸盐阻断。结论:尼可地尔通过开放mitoKATP通道降低肺动脉压,拮抗右心肥厚,并抑制肺血管增殖重构,治疗低氧性肺高压。 Objective:To investigate the effects of nicorandil,a mitochondria adenosine triphosphate(ATP)-sensitive potassium channel opener(mitoKATPCO) on the development of hypoxic pulmonary hypertension(HPH) in rats.Methods: Forty rats were randomly divided into 4 groups(control group and three hypoxic groups including the simple hypoxic,nicorandil treatment as well as the nicorandil+5-hydroxydecanoate treatment group) with 10 rats each.The latter three hypoxic groups were placed into normobaric hypoxic chamber(8 h/day and 6 days/week).After 4 weeks,the mean pulmonary arterial pressure(mPAP),right ventricle/left ventricle and septum[RV/(LV+S)] were measured and the morphologic changes of small pulmonary arterial were detected by microscopes after hematoxylin-eosin staining.Western blot was performed to analyze the protein expression of proliferating cell nuclear antigen(PCNA).Results: Hypoxia alone significantly increased the mPAP,RV/(LV+S) as well as the protein expression of PCNA,the morphologic changes also indicated the significant proliferation and remodeling of the small pulmonary artery in the hypoxic group.The treatment with nicorandil significantly antagonized these changes,and the beneficial effects of nicorandil could be blocked by 5-HD.Conclusion: Nicorandil can significantly reduce the pulmonary artery pressure,antagonize the right ventricular hypertrophy as well as the proliferation and remodeling of the small pulmonary artery through activating the mitoKATP channel.It is a promising candidate for the treatment of HPH.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2012年第3期364-368,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省"六大人才高峰"第五批高层次人才项目(B类)
关键词 低氧性肺高压 尼可地尔 mitoKATP通道 hypoxic pulmonary hypertension(HPH) nicorandil mitoKATP channel
  • 相关文献

参考文献18

  • 1Stenmark KR,Fagan KA,Frid MC,et al.Hypoxia-inducedpulmonary vascular remodeling:cellular and molecularmechanisms[J].Circ Res,2006,99(7):675-691.
  • 2Hongo M,Mawatari E,Sakai A,et al.Effects of nicorandilon monocrotaline-induced pulmonary arterial hypertensionin rats[J].J Cardiovasc Pharmacol,2005,46(4):452-458.
  • 3吕剑,解卫平,左祥荣,宗峰,王慧,王虹.新型K_(ATP)开放剂埃他卡林对慢性低氧诱导大鼠体内肺动脉平滑肌K_(ATP)通道mRNA表达变化的影响[J].中国药理学通报,2009,25(11):1421-1425. 被引量:1
  • 4Simonneau G,Robbins IM,Beghetti M,et al.Updated clin-ical classification of pulmonary hypertension[J].J Am CollCardiol,2009,54(1 Suppl):S43-54.
  • 5宗峰,左祥荣,王慧,吕剑,解卫平,王虹.新型K_(ATP)开放剂埃他卡林对低氧性肺动脉高压大鼠血管活性物质的影响[J].实用老年医学,2010,24(3):206-208. 被引量:4
  • 6Fishman AP,Fishman MC,Freeman BA,et al.Mecha-nisms of proliferative and obliterative vascular diseases:insights from the pulmonary and systemic circulations[J].Am J Respir Crit Care Med,1998,158(2):670-674.
  • 7Yi ES,Kim H,Ahn H,et al.Distribution of obstructive in-timal lesions and their cellular phenotypes in chronic pul-monary hypertension:a morphometric and immunohisto-chemical study[J].Am J Respir Crit Care Med,2000,162(4 Pt1):1577-1586.
  • 8王毅,解卫平,王虹,周燕娟,李庆玲.Iptakalim对低氧诱导的人肺动脉平滑肌细胞增殖及TGF-β和PCNA表达的影响[J].中国生化药物杂志,2010,31(3):158-161. 被引量:2
  • 9Ko EA,Han J,Jung ID,et al.Physiological roles of K+channels in vascular smooth muscle cells[J].J SmoothMuscle Res,2008,44(2):65-81.
  • 10Seino S.ATP-sensitive potassium channels:a model ofheteromultimeric potassium channel/receptor assemblies[J].Annu Rev Physiol,1999,61:337-362.

二级参考文献44

共引文献11

同被引文献35

  • 1高敏,汪海.血管平滑肌ATP敏感性钾通道研究进展[J].中国药理学通报,2004,20(8):845-849. 被引量:4
  • 2冯力,邱健,马骏,黄小波,查道刚,宾建平.缺血-再灌注不同时间点给予尼可地尔对犬心肌梗死范围的影响[J].中国危重病急救医学,2005,17(3):157-160. 被引量:5
  • 3赵京林,杨跃进,尤士杰,荆志成,吴永健,杨伟宪,孟亮,田毅,陈纪林,高润霖,陈在嘉.尼可地尔对猪急性心肌梗死再灌注后无再流的影响[J].中国危重病急救医学,2005,17(7):421-425. 被引量:10
  • 4张鸿,刘艳艳,马英,吕永利.ATP敏感性钾通道开放剂对脑缺血/再灌注损伤的保护作用及信号转导机制研究[J].中国危重病急救医学,2007,19(4):221-224. 被引量:17
  • 5Hassoun PM,Mouthon L,Barbera JA,et al. Inflamma- tion, growth factors, and pulmonary vascular remodeling [J]. J Am Coil Cardiol,2009,54( 1 Suppl):S10-19.
  • 6Lambert CM,Roy M,Meloche J,et al. Tumor necrosis factor inhibitors as novel therapeutic tools for vascular- remodeling diseases[J]. Am J Physiol Heart Circ Physi- ol, 2010,299 (4) : H995-1001.
  • 7Caminero A, Comabella M, Montalban X. Tumor necrosis factor alpha (TNF-alpha), anti-TNF-alpha and demyeli- nationrevisited: an ongoing story [J]. J Neuroimmunol,2011,234(1-2):1-6.
  • 8Joppa P, Petrasova D, Stancak B, et al. Systemic inflam- mation in patients with COPD and pulmonary hyperten- sion[J]. Chest, 2006, 130(2): 326-333.
  • 9Wang Y, Jing L, Zhao XM, et al. Protective effects of hy- drogen-rich saline on monocrotaline-induced pulmonary- hypertension in a rat model[J]. Respir Res, 2011,12 : 26.
  • 10Sutendra G,Dromparis P,Bonnet S,et al. Pyruvate dehy- drogenase inhibition by the inflammatory cytokine TNFal- phacontributes to the pathogenesis of pulmonary arterial hypertension[J] Mol Med (Bed),2011,89(8) :771-783.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部